{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-071145","form_type":"8-K","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2024-08-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.336531+00:00","generated_at":"2026-05-31T08:24:43.098413+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"ABVC BioPharma updates corporate presentation; no material new details disclosed","bullets":["Company filed Form 8-K furnishing an updated corporate presentation on August 20, 2024.","Filing text and exhibit provide no specific financial data, milestones, or strategic changes.","No guidance, partnerships, product developments, or other substantive updates revealed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-071145","json":"https://secwatch.observer/filing/0001213900-24-071145.json","markdown":"https://secwatch.observer/filing/0001213900-24-071145.md","text":"https://secwatch.observer/filing/0001213900-24-071145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024071145/0001213900-24-071145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024071145/ea0211916-8k_abvc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:24:43.098413+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}